GTHP director granted 110,000 stock options
GUIDED THERAPEUTICS INC director Alan Grujic received a grant of stock options covering 110,000 shares of Common Stock.
Rhea-AI Filing Summary
GUIDED THERAPEUTICS INC director Alan Grujic received a grant of stock options covering 110,000 shares of Common Stock. The options have an exercise price of $0.29 per share and expire on March 9, 2036, providing potential future equity if exercised.
According to the vesting terms, one-fourth of the options vested on March 10, 2026. The remaining options will vest in monthly installments starting on June 10, 2026, subject to Grujic’s continued service, until fully vested on March 9, 2029. This filing reflects a compensation-related award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 110,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. One-fourth of the shares subject to the award vested on March 10,2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 9, 2029.
Key Figures
Key Terms
Stock Options financial
exercise price financial
vesting financial
Common Stock financial
FAQ
What insider transaction did GUIDED THERAPEUTICS (GTHP) report for Alan Grujic?
What is the exercise price of Alan Grujic’s GTHP stock options?
What is the vesting schedule for Alan Grujic’s GTHP stock options?
When do Alan Grujic’s GUIDED THERAPEUTICS stock options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.